93
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Effects of Interferon-α on Cell Cycle Regulatory Proteins in Leukemic Cells

, , , , &
Pages 1019-1025 | Published online: 01 Jul 2009

  • Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. andSchreiber, R.D. (1998) "How cells respond to interferons". Annu. Rev. Biochem. 67, 227-264.
  • De Mayer, E. and De Meyer-Guiginard, J. (1998) Interferons and Other Regulatory Cytokines (Wiley, New York).
  • Einhorn, S. and Strander, H. (1993) "Interferon treatment of human malignancies-a short review". Med. Oncol. Tumor Pharmacother.10, 25-29.
  • Wetzler, M., Kantarjian, H., Kurzrock, R. and Talpaz, M. (1995) "Interferon-alpha therapy for chronic myelogenous leukemia",Am. J. Med. 99, 402-411.
  • Einhorn, S., Öst, A., Grimfors, G., Grander, D. and Björkholm, M.(1990) "Prolonged remission induced by interteron-alpha in a patient with refractory T-cell ALL", Lancet 335. 794-795.
  • Pangalis, G.A. and Griva, E. (1988) "Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocyticleukemia". Cancer 61, 869-872.
  • Mellstedt, H., Aahre, A., Bjorkholm, M., Cantell, K., Holm, G., Johansson, B. and Strander, H. (1979) "Interferon therapy in myelomatosis", Lancet 2, 697.
  • Merigan, T.C., Sikora, K., Breeden, J.H., Levy, R. and Rosenberg,S.A. (1978) "Preliminary observations on the effect of human leukocyte Interferon in non-Hodgkin's lymphoma". N. Engl J. Med. 299, 1449- 1453.
  • Brenning, G., Ahre, A. and Nilsson, K. (1985) "Correlation betweenin vivo and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma". Scand J. Haematol. 35, 543-549.
  • Grana, X. and Reddy, E.P. (1995) "Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs). Growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)".Oncogene 11, 211-219.
  • Sherr, C.J. and Roberts, J.M. (1995) "Inhibitors of mammalian Gl cyclin-dependent kinases". Genes Dev. 9, 1149-1163.
  • Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995) "Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta". Genes Dev 9, 1831-1845.
  • Sangfelt, O., Erickson, S., Einhorn, S. and Grander, D. (1997)"Induction of Clip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines". Oncogene 14, 415-423.
  • Sangfelt, O., Erickson, S., Castro, J., et al. (1999) "Molecular mechanisms underlying interferon-alpha-induced GO/Gl arrest: CKl-mediated regulation of G1 Cdk-complexes and activation of pocket proteins". Oncogens 18, 2798-2810.
  • Subramaniam, P.S., Cruz, P.E., Hobeika, A.C and Johnson, H.M. (1998) "Type I Interferon induction of the Cdk-inhibitor p21WAFl is accompanied by ordered GI arrest, differentiation and apoptosis of the Daudi B-cell line". Oncogene 16, 1885-1890
  • Mandal, M., Bandyopadhyay, D., Goepfert, T.M. and Kumar, R. (1998) "Interferon-induces expression of cyclin-dependent kinaseinhibitors p21WAFI and p27Kipl that prevent activation of cyclindependent kinase by CDK-activating kinase (CAK)", Oncogene 16, 217-225.
  • Matsuoka, M., Tani, K. and Asano, S. (1998) "Interferon-alphainduced Gl phase arrest through up-regulated expression of CDK inhibitors. p19Ink4D and p21Cipl in mouse macrophages". Oncogene 16, 2075-2086.
  • Roos, G., Leanderson, T. and Lundgren, K. (1984) "Interferoninduced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells". Cancer Rev. 44, 2358-2362.
  • Einhorn, S., Vanky, F., Grander, D. and Willems, J.S. (1997) "Induction of 2'.5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon". Eur. J. Cancer Clin. Oncol. 23. 1607-1613."
  • Sangfelt, O., Erickson, S. and Grander, D. (2000) "Mechanisms of interferon-induced cell cycle arrest", Front. Biosci. 5, 479-487.
  • Radosevic, N., Delmer, A., Tang, R., Marie, J.P. and Ajchenbaum-Cymbalista, F. (2001) "Cell cycle regulatory protein expression in fresh acute mycloid leukemia cells and after drug exposure". Leukemia 15, 559-566.
  • Vrhovac, R., Delmer, A., Tang, R., Marie, J.P., Zittoun, R. and Ajchenbaum-Cymbalista, F. (1998) "Prognostic significance of the cell cycle inhibitor p27Kipl in chronic B-cell lymphocytic leukaemia". Blood 91, 4694-4700.
  • Wolowiec, D, Benehaib, M., Pemas, P., et al., (1995) "Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue", Leukemia 9, 1382-1388.
  • Scuderi, R., Palucka, K.A., Pokrovskaja, K., Bjorkholm, M., Wiman, K.G. and Pisa, P. (1996) "Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage". Blood 87, 3360-3367.
  • Volm, M., Koomagi, R., Stammler, G., Rittgen, W., Zintl, F. and Sauerbrey, A. (1997) "Prognostic implications of cyclins (DI. E. A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p161NK4A) in childhood acute lymphoblastic leukemia". Int. J. Cancer 74, 508-512.
  • Yokozawa, T., Towatari, M., Iida, H., et al. (2000) "Prognostic significance of the cell cycle inhibitor p27Kipl in acute mycloid leukemia". Leukemia 14, 28-33.
  • Sandhu, C. and Slingerland, J. (2000) "Deregulation of the cell cycle in cancer", Cancer Detect. Prev. 24, 107-118.
  • Ekholm, S.V., Zickert, P., Reed, S.I. and Zetterberg, A. (2001) "Accumulation of Cyclin E is not a prerequisite for passage through the restriction point". Mol. Cell. Biol. 21, 3256-3265
  • Östlund, L., Grander, D., Juliusson, G., Robert, K.H., Lundgren, E. and Einhorn, S. (1989) "Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation". Cancer Res. 49, 3425-3430.
  • Erickson, S., Sangfelt, O., Castro, J., Heyman, M., Einhom, S. and Grander, D. (1999) "Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cycle-regulatory proteins". Cell Growth Differ 10, 575-582.
  • Claassen, G.F. and Hann, S.R. (2000) "A role for transcriptional repression of p2IClPl by c-Myc in overcoming transforming growth factor", Proc. Natl Acad. Sci. USA 97, 9498-9503.
  • Xu, B., Grander, D., Sangfelt, O. and Einhorn, S. (1994) "Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3". Blood 84, 1942-1949.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.